title: Current and future options for treating esophageal cancer: a paradigm shift toward organ-sparing therapies.
authors.affiliation: Department of Thoracic and Cardiovascular Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. whofstetter@mdanderson.org
authors.forename: Wayne
authors.initials: W
authors.lastname: Hofstetter
mesh_terms: D003131:Combined Modality Therapy / Q000379:methods / Q000639:trends; D004938:Esophageal Neoplasms / Q000175:diagnosis / Q000601:surgery*; D016629:Esophagectomy / Q000379:methods* / Q000639:trends*; D006801:Humans; D009367:Neoplasm Staging
keywords: Antineoplastic combined chemotherapy protocols; carcinoma, squamous cell; chemoradiotherapy; combined modality therapy; esophageal neoplasms/drug therapy/radiotherapy/surgery; esophagectomy; lymphatic metastasis; neoadjuvant therapy; neoplasm recurrence, local; neoplasm staging; salvage therapy